Health News from Medical News Today: Glaxo Moves On New COPD Med Relovair As Advair Patent Expire Looms

Health News from Medical News Today Latest Health News and Medical News posted throughout the day, every day. Glaxo Moves On New COPD Med Relovair As Advair Patent Expire Looms 2 Jun 2011, 6:00 pm GlaxoSmithKline is already the asthma treatment industry leader with its Advair product and 2007 sales of US $6.9 billion. It will likely remain the market leader in the current generation of asthma medication, being a combination drug consisting of a corticosteroid and a long-acting beta antagonist. However, Advair's patent protection expires in both the United States and Europe in the next few years... You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed.